Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiankunning
- Development stage
- Unknown
- Lead developer
- Enwei Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qiankunning is a Traditional Chinese Medicine (TCM) formulation developed by Chengdu Enwei Pharmaceutical Co., Ltd. for the treatment of HIV infection and Acquired Immunodeficiency Syndrome (AIDS). Composed of multiple herbal extracts, the drug is designed to function as an antiviral agent that inhibits HIV replication while providing immunomodulatory effects to bolster the patient's immune system. Clinical trials conducted in China, including Phase II and Phase III studies, have demonstrated its potential to reduce HIV-1 viral load and increase CD4+ T-lymphocyte counts in infected individuals. The therapeutic effect is believed to result from the synergistic action of its natural components, which may interfere with viral entry and the activity of the reverse transcriptase enzyme.
- Brand names
- Qiankunning
- Other names
- Qiankunning CapsulesQian Kun Ning
02
Targets
Human immunodeficiency virus type 1 reverse transcriptase
Beyond the preview
Go deeper on Qiankunning.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qiankunning.